Budget Impact Analysis Of Adopting Evolocumab In The Brazilian Private Healthcare System For Patients With Uncontrolled LDL-C And High Cardiovascular Risk
Abstract
Authors
RF dos Santos FP Alves M Urbich G Villa PS Farsky
RF dos Santos FP Alves M Urbich G Villa PS Farsky
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now